Emerging Company Showcase

The Immuno-Oncology Investing and Partnering Forum will play host to an Emerging Company Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.

To be eligible to participate, companies must be:

  • Addressing an unmet medical need
  • Founded no earlier than 2013
  • Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2017 are not eligible for this showcase)

Please note that all companies must have a valid email address and phone number to be eligible for participation in the Emerging Company Showcase. A recent news article or webpage from a investor or parent company may be submitted in lieu of a company website. Selected companies will receive a discounted registration rate of $500 for the Immuno-Oncology Investing and Partnering Forum.


* Name of Company:  
Area of Immuno-Oncology  
* Year Foundeded:
Company Representative:
Executive Summary:  
Unmet medical need that your company seeks to fill:  
* Funding received to date:


* First Name:  
* Last Name:  
* Job Title:
* Company Name:  
* Address:
* City:
* State/Province 
* Zip:
* Country:
* Phone Ext:  
* Email:
* Company Website: